Details of the Drug

General Information of Drug (ID: DM9PSZ1)

Drug Name

BBP-812

Indication

Disease Entry	ICD 11	Status	REF
Canavan disease	5C50.E1	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04998396) A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Adrenas Therapeutics